Etomidate [3] (USAN, INN, BAN; marketed as Amidate) is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation [4] for short procedures such as reduction of dislocated joints, tracheal intubation, cardioversion and electroconvulsive therapy.

2023年6月26日 · Etomidate is an ultrashort-acting, non-barbiturate hypnotic intravenous anesthetic agent. It is administered only by intravenous route. Etomidate has a favorable hemodynamic profile on induction, with minimal blood pressure depression, making it ideal for shock trauma, hypovolemic patients, or patients with significant cardiovascular disease.

2024年1月13日 · Generic name: Etomidate [ e-TOM-i-date ] Brand name: Amidate Drug class: General anesthetics. Medically reviewed by Drugs.com. Last updated on Jan 13, 2024. Uses; Before taking; Warnings; Directions; Side effects; Overdose; Uses of Etomidate: It is used to put you to sleep for surgery. It may be given to you for other reasons. Talk with the doctor.

在臺灣，甲苄咪酯（依托咪酯）於2023年起自中國大陸輸入，混合化學物被提煉、混合成電子煙油，再分裝成電子煙彈，因其所生症狀，被以「喪屍煙彈」、「喪屍毒品」或「上頭電子煙」等名販售。 由於取得便利，因吸食該電子煙所生刑事案件及道路交通事故日增，法務部毒品審議委員會於2024年6月13日通過會議審議，預告修正「毒品危害防制條例」第二條附表三，將依托咪酯（即甲苄咪酯）增列為第三級毒品管制，法制作業完成後即公告列管。 [11][12] 依托咪酯原本被列為 …

Medscape - Indication-specific dosing for Amidate (etomidate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

2024年2月22日 · 依託咪酯(Etomidate)是一種短效的非巴比妥類麻醉藥，能與中樞神經系統的γ-GABA（γ-氨基丁酸）感受器結合，增強其抑制作用，從而產生鎮靜和催眠效果。

2024年12月15日 · Etomidate is a general anesthetic without analgesic activity. Intravenous injection of etomidate produces anesthesia characterized by a rapid onset of action, usually within one minute. Duration of anesthesia is dose dependent but relatively brief, usually three to five minutes when an average dose of 0.3 mg/kg is employed.

Etomidate的藥理作用 具短效性麻醉作用，以靜脈注射，使細胞的鈉離子通道維持在不活化的狀態，並使感覺的神經訊息無法傳遞，而能止痛、麻醉。 為靜脈注射的短效麻醉劑，使感覺的神經訊息無法傳遞，而能止痛、麻醉。

Etomidate is a non-barbiturate hypnotic that acts at the level of the reticular-activating system to produce anesthesia. Etomidate is an imidazole compound that appears to depress CNS function via GABA. Duration of action is intermediate between thiopental and methohexital, and recovery from a single dose is rapid with little residual depression.

Etomidate is an imidazole-based agonist of the γ-aminobutyric acid type A (GABA A) receptor used for the induction of general anesthesia and sedation. It was initially developed as an antifungal agent in 1964 by Janssen Pharmaceuticals, but during animal studies, its hypnotic effect was serendipitously observed [1].